Want to see AVR full AI Analyst Report?

Anteris Technologies Global Corp. (AVR) Price & Analysis

94 Followers

AVR Stock Chart & Stats

$8.13

$0.04(0.49%)

At close: Jul 27 4:00 PM EDT

$8.13

$0.04(0.49%)

Day’s Range― - ―

52-Week Range$3.30 - $11.06

Previous Close$8.18

Volume838.13K

Average Volume (3M)151.40K

Market Cap

$866.41M

Enterprise Value$705.02

Total Cash (Recent Filing)$257.38M

Total Debt (Recent Filing)$3.32M

Price to Earnings (P/E)―

Beta1.90

Next Earnings

Nov 18, 2026

EPS Estimate

-0.31

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.76

Shares Outstanding97,458,470

10 Day Avg. Volume215,658

30 Day Avg. Volume151,395

Financial Highlights & Ratios

PEG Ratio0.06

Price to Book (P/B)-1.98K

Price to Sales (P/S)96.28

P/FCF Ratio-2.31

Enterprise Value/Market Cap<0.01

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda>-0.01

Forecast

1Y Price Target

$15.33

Price Target Upside88.60% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

EPS Forecast (FY)-1.2

Revenue Forecast (FY)$8.88M

Bulls Say, Bears Say

Bulls Say

Revenue And Gross Margin ImprovementImproving revenue and gross margin indicate growing commercial traction and better product economics. If sustained, this progress could provide operating leverage as Anteris advances its structural-heart devices toward broader adoption.

Low Financial LeverageMinimal debt reduces interest and refinancing pressure, giving Anteris greater flexibility to fund clinical, regulatory, and development programs. The sizable equity base also provides a stronger cushion while the company remains pre-profit.

Structural Heart Technology FocusAnteris targets structural heart disease through valve and delivery-system technologies, an area supported by ongoing clinical need. A focused platform strategy could create durable product opportunities if development and regulatory milestones are achieved.

Bears Say

Deep And Expanding LossesSevere losses show that revenue has not yet reached a scale capable of covering operating costs. Continued expense growth without corresponding commercial expansion could prolong dependence on external financing and delay sustainable profitability.

Persistent Cash BurnLarge, recurring cash outflows constrain the resources available for clinical trials, manufacturing, and commercialization. Unless cash conversion improves, Anteris may need repeated funding, creating dilution risk and reducing strategic flexibility.

Small Scale And Weak Cost AbsorptionA small revenue base limits the company’s ability to absorb research, regulatory, and corporate expenses. The combination of growth and widening operating losses suggests costs are not yet scaling efficiently, weakening the path to durable margins.

Anteris Technologies Global Corp. News

Court Orders Enable Anteris Trading Halt to Lift

Anteris Technologies Global Corp. ( ($AVR) ) has provided an update. On August 3, 2026, Anteris Technologies Global...

25d ago

AVR

Anteris Technologies Requests ASX Trading Halt for Relief

Anteris Technologies Global Corp. ( ($AVR) ) has shared an update. On July 31, 2026, Anteris Technologies Global...

28d ago

AVR

Anteris Technologies files to sell 5.39M shares of common stock

17:14 EDT Anteris Technologies (AVR) files to sell 5.39M shares of common stock Published first on TheFly –...

2M ago

AVR

Anteris Technologies cleared by ANSM for DurAVR THV trial

Anteris Technologies (AVR) announced that it has received full regulatory clearance from the French National Agency for Medicines...

3M ago

AVR

Anteris Launches $250 Million At-The-Market Stock Program

Anteris Technologies Global Corp. ( ($AVR) ) has provided an announcement. On May 22, 2026, Anteris Technologies Global...

3M ago

AVR

AVR Earnings this Week: How Will it Perform?

Anteris Technologies Global Corp. (AVR) is scheduled to report 1st quarter earnings on 05/19/2026, after the market closes....

3M ago

AVR

Anteris Technologies price target raised to $18 from $17 at Barclays

Barclays raised the firm’s price target on Anteris Technologies (AVR) to $18 from $17 and keeps an Overweight...

3M ago

AVR

Anteris Technologies Adds Experienced Financial Leaders to Board

Anteris Technologies Global Corp. ( ($AVR) ) just unveiled an update. On May 11, 2026 in the U.S....

4M ago

AVR

Anteris Technologies: First U.S. patients treated in global PARADIGM trial

Anteris Technologies (AVR) announced that the first patients in the United States have been enrolled and successfully treated...

4M ago

AVR

Anteris Ends v2vmedtech Development Agreement, Limits Exposure

An update from Anteris Technologies Global Corp. ( ($AVR) ) is now available. On April 28, 2026, Anteris...

4M ago

AVR

Anteris Technologies secures CMS reimbursement for trial site activation

Anteris Technologies (AVR) has secured U.S. Medicare reimbursement eligibility for the global pivotal PARADIGM Trial under a Centers...

4M ago

AVR

Anteris Technologies Signs Major Brooklyn Park Facility Lease

Anteris Technologies Global Corp. ( ($AVR) ) has provided an update. On April 23, 2026, Anteris Technologies Global...

4M ago

AVR

Anteris Technologies participates in a conference call with Cantor Fitzgerald

Conference call with management to be held on March 26 at 10 am hosted by Cantor Fitzgerald. Webcast...

5M ago

AVR

AVR Upcoming Earnings Report: What to Expect?

Anteris Technologies Global Corp. (AVR) is scheduled to report 4th quarter earnings on 03/18/2026. Regarding Q4 estimates, Wall...

5M ago

AVR

AVR FAQ

What was Anteris Technologies Global Corp.’s price range in the past 12 months?

Anteris Technologies Global Corp. lowest stock price was $3.30 and its highest was $11.05 in the past 12 months.

What is Anteris Technologies Global Corp.’s market cap?

Anteris Technologies Global Corp.’s market cap is $866.41M.

When is Anteris Technologies Global Corp.’s upcoming earnings report date?

Anteris Technologies Global Corp.’s upcoming earnings report date is Nov 18, 2026 which is in 82 days.

How were Anteris Technologies Global Corp.’s earnings last quarter?

Anteris Technologies Global Corp. released its earnings results on Aug 11, 2026. The company reported -$0.3 earnings per share for the quarter, missing the consensus estimate of -$0.207 by -$0.093.

Is Anteris Technologies Global Corp. overvalued?

According to Wall Street analysts Anteris Technologies Global Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Anteris Technologies Global Corp. pay dividends?

Anteris Technologies Global Corp. does not currently pay dividends.

What is Anteris Technologies Global Corp.’s EPS estimate?

Anteris Technologies Global Corp.’s EPS estimate is -0.31.

How many shares outstanding does Anteris Technologies Global Corp. have?

Anteris Technologies Global Corp. has 97,458,470 shares outstanding.

What happened to Anteris Technologies Global Corp.’s price movement after its last earnings report?

Anteris Technologies Global Corp. reported an EPS of -$0.3 in its last earnings report, missing expectations of -$0.207. Following the earnings report the stock price went down -3.272%.

Which hedge fund is a major shareholder of Anteris Technologies Global Corp.?

Currently, no hedge funds are holding shares in AVR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Anteris Technologies Global Corp. Stock Smart Score

Neutral

Fundamentals

Return on Equity

―

Trailing 12-Months

Asset Growth

583.35%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Anteris Technologies Global Corp.

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Anteris Technologies Global Corp. (AVR) Earnings & Revenues

Historic Earnings Reports

AVR Stock 12 Month Forecast

Average Price Target

$15.33

▲(88.60% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","17":"$17","5.75":"$5.75","9.5":"$9.5","13.25":"$13.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.333333333333334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.75,9.5,13.25,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.84,8.467692307692307,9.095384615384615,9.723076923076922,10.350769230769231,10.978461538461538,11.606153846153845,12.233846153846153,12.861538461538462,13.489230769230769,14.116923076923076,14.744615384615384,15.372307692307691,{"y":16,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.84,8.416410256410256,8.992820512820513,9.569230769230769,10.145641025641027,10.722051282051282,11.298461538461538,11.874871794871794,12.451282051282051,13.027692307692309,13.604102564102565,14.18051282051282,14.756923076923076,{"y":15.333333333333334,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.84,8.39076923076923,8.941538461538462,9.492307692307692,10.043076923076923,10.593846153846155,11.144615384615385,11.695384615384615,12.246153846153845,12.796923076923077,13.347692307692308,13.89846153846154,14.44923076923077,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.07,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.11,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.25,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.49,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.04,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.99,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.15,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.62,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.32,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.36,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.1,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.94,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.84,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >